Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Cyclic-alkylamine derivatives as inhibitors of the interaction between MDM2 and p53

Cyclic-alkylamine derivatives as inhibitors of the interaction between MDM2 and p53

US Patent 8088795 · Granted Jan 3, 2012

Estimated economic value: $122,734,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Spiropiperidine allosteric modulators of nicotinic acetylcholine receptors2025
Cyclic compounds as receptor modulating therapeutics and methods and uses thereo2025
Substituted-N-heteroaryl compounds and uses thereof2024
Substituted-pyridinyl compounds and uses thereof2024
Inhibitors of the interaction between MDM2 and P532023
(R)-8-(1-((3-fluorophenyl)amino)ethyl)-N-(2-hydroxyethyl)-2-morpholinoquinoxalin2022
Quinoxaline and pyridopyrazine derivatives as PI3K-beta inhibitors2021
Cosmetic compositions and method of treating the skin2021
Bicyclic pyridine, pyrazine, and pyrimidine derivatives as PI3K beta inhibitors2021
Deoxyuridine triphosphatase inhibitors2021
Quinoxaline and pyridopyrazine derivatives as PI3Kβ inhibitors2020
Heteroatom containing deoxyuridine triphosphatase inhibitors2019